Phosphotyrosine phosphatase activity prevents the detection of P210bcr/abl protein in mature cells in chronic myelogenous leukemia even by an immunoblotting technique
- PMID: 2474729
Phosphotyrosine phosphatase activity prevents the detection of P210bcr/abl protein in mature cells in chronic myelogenous leukemia even by an immunoblotting technique
Abstract
P210bcr/abl protein with tyrosine protein kinase has been implicated in the proliferation and differentiation of chronic myelogenous leukemia cells. Using an immunoblotting technique with antiphosphotyrosine (anti-P-Tyr) antibodies, we examined whether P210bcr/abl protein was expressed in chronic phase cells in patients with chronic myelogenous leukemia (CML). We could detect P210bcr/abl protein in blast cells regardless of myeloid or lymphoid lineage but not in chronic phase cells from patients. However, in a patient with both blast cells and chronic phase cells, we could identify the protein only after the enrichment of the blast crisis cells by Percoll gradient centrifugation. When K562 cells were mixed with mature granuloid cells, the P210bcr/abl in K562 cells detected by immunoblotting was decreased. Using phosphotyrosyl proteins in K562 cells as substrates, high phosphotyrosyl (P-Tyr) phosphatase activity was observed, not only in the lysate of chronic phase cells from CML patients but also in the lysate of neutrophils from normal subjects. These findings suggest the possibility that high P-Tyr phosphatase activity prevents the detection of P210bcr/abl in CML cells in the chronic phase. The activity may be characteristic of mature cells and may regulate cellular events through dephosphorylation of P210bcr/abl.
Similar articles
-
Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.Cancer Res. 1987 Mar 15;47(6):1731-9. Cancer Res. 1987. PMID: 2434223
-
Detection of P210bcr-abl in mature granulocytes from Ph1-positive chronic myelogenous leukemia patients by an immunoblotting method.Leukemia. 1993 Aug;7(8):1168-73. Leukemia. 1993. PMID: 8350617
-
A 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populations.Leukemia. 1994 Apr;8(4):688-93. Leukemia. 1994. PMID: 8152267
-
Protein tyrosine kinases associated with human malignancies.Ann N Y Acad Sci. 1987;511:256-61. doi: 10.1111/j.1749-6632.1987.tb36253.x. Ann N Y Acad Sci. 1987. PMID: 2449839 Review. No abstract available.
-
Phosphorylation of estradiol receptor on tyrosine and interaction of estradiol and glucocorticoid receptors with antiphosphotyrosine antibodies.Adv Exp Med Biol. 1988;231:519-40. doi: 10.1007/978-1-4684-9042-8_44. Adv Exp Med Biol. 1988. PMID: 2458018 Review. No abstract available.
Cited by
-
Induction of protein-tyrosine-phosphatase activity by interleukin 6 in M1 myeloblastic cells and analysis of possible counteractions by the BCR-ABL oncogene.Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):477-81. doi: 10.1073/pnas.90.2.477. Proc Natl Acad Sci U S A. 1993. PMID: 8421678 Free PMC article.
-
A phosphatase activity present in peripheral blood myeloid cells of chronic myelogenous leukemia patients but not normal individuals alters nuclear protein binding to transcriptional enhancers of interferon-inducible genes.J Clin Invest. 1990 Nov;86(5):1664-70. doi: 10.1172/JCI114889. J Clin Invest. 1990. PMID: 2243138 Free PMC article.
-
Altered Ca2+ homeostasis in polymorphonuclear leukocytes from chronic myeloid leukaemia patients.Mol Cancer. 2006 Nov 27;5:65. doi: 10.1186/1476-4598-5-65. Mol Cancer. 2006. PMID: 17129370 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous